trial · primary record
gp91 Grans
Chronic Granulomatous Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2027-07-01 |
| Primary endpoint | Feasibility: Recruitment, implementation, and manufacturing of gp91-Grans for infusions. |
| Registry ID | NCT05189925 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:04.702Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05189925
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.